110 related articles for article (PubMed ID: 8247632)
21. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
22. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
Goldstein FW; Coutrot A; Sieffer A; Acar JF
Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
24. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
Cohen R; Barre J; Varon E
Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
[TBL] [Abstract][Full Text] [Related]
25. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
[TBL] [Abstract][Full Text] [Related]
26. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
27. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
Caiaffa Filho HH; Lima Mde P; Sinto SI; Andriolo A; Mendes CM
Rev Assoc Med Bras (1992); 1994; 40(2):77-80. PubMed ID: 7820154
[TBL] [Abstract][Full Text] [Related]
28. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
29. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
31. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
[TBL] [Abstract][Full Text] [Related]
33. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
Sieradzki K; Villari P; Tomasz A
Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the antimicrobial susceptibilities of coagulase-negative staphylococci by E-test.
Barelli C; Minto EC; Martinez R; Darini AL
Rev Latinoam Microbiol; 1999; 41(2):67-72. PubMed ID: 10932753
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
Samra Z; Ofer O; Shmuely H
Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
[TBL] [Abstract][Full Text] [Related]
37. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
[TBL] [Abstract][Full Text] [Related]
38. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
39. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibility to selected coagulase-negative chemotherapeutic agents of methicillin resistant staphylococci isolated from clinical materials in 1997-1998].
Kochman M; Fordymacki P; Ławrynowicz-Paciorek M; Kałuzewski S; Meszaros J; Połowniak-Pracka H; Magdziak A; Sztandar-Sztanderska M
Med Dosw Mikrobiol; 2000; 52(4):341-52. PubMed ID: 11286176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
